Letter to the Editor: The pathological impact of PAR2 on hepatic insulin resistance
- PMID: 36869844
- DOI: 10.1097/HEP.0000000000000284
Letter to the Editor: The pathological impact of PAR2 on hepatic insulin resistance
Comment on
-
PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference.Hepatology. 2022 Dec;76(6):1778-1793. doi: 10.1002/hep.32589. Epub 2022 Jun 11. Hepatology. 2022. PMID: 35603482 Free PMC article.
References
-
- Shearer AM, Wang Y, Fletcher EK, Rana R, Michael ES, Nguyen N, et al. PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference. Hepatology. 2022;76:1778–93.
-
- Wang J, Chakrabarty S, Bui Q, Ruf W, Samad F. Hematopoietic tissue factor-protease-activated receptor 2 signaling promotes hepatic inflammation and contributes to pathways of gluconeogenesis and steatosis in obese mice. Am J Pathol. 2015;185:524–35.
-
- Lim J, Iyer A, Liu L, Suen JY, Lohman RJ, Seow V, et al. Diet-induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism. FASEB J. 2013;27:4757–67.
-
- Kim BM, Kim DH, Park YJ, Ha S, Choi YJ, Yu HS, et al. PAR2 promotes high-fat diet-induced hepatic steatosis by inhibiting AMPK-mediated autophagy. J Nutr Biochem. 2021;95:108769.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
